To make matter worse, Remdesivir is a drug that “has had its development costs paid for, in large part, by independent donors like governments and ministries of health in China, the WHO, and the US government.”
Continue reading COVID19 Profiteering: Gilead Charges $3000 for Remdesivir that Costs Pennies to Produce